Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013.
about
Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence.Is there evidence of potential overtreatment of glycaemia in elderly people with type 2 diabetes? Data from the GUIDANCE study.Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome Studies.Achievement of Glycated Hemoglobin Goals in the US Remains Unchanged Through 2014.Should Side Effects Influence the Selection of Antidiabetic Therapies in Type 2 Diabetes?Evidence connecting old, new and neglected glucose-lowering drugs to bile acid-induced GLP-1 secretion: A review.Efficacy and safety of ipragliflozin and metformin for visceral fat reduction in patients with type 2 diabetes receiving treatment with dipeptidyl peptidase-4 inhibitors in Japan: a study protocol for a prospective, multicentre, blinded-endpoint phaComparative safety of pioglitazone versus clinically meaningful treatment alternatives concerning the risk of bladder cancer in older US adults with type 2 diabetes.Diabetes and Aging: Unique Considerations and Goals of Care.Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016).Type 2 diabetes in general practice in Norway 2005-2014: moderate improvements in risk factor control but still major gaps in complication screening.Changes in Antidiabetic Drug Prescription and Glycemic Control Trends in Elderly Patients with Type 2 Diabetes Mellitus from 2005-2013: An Analysis of the National Center Diabetes Database (NCDD-03).Exposure to Night-Time Traffic Noise, Melatonin-Regulating Gene Variants and Change in Glycemia in Adults.The Association of Severe Hypoglycemia With Incident Cardiovascular Events and Mortality in Adults With Type 2 Diabetes.Working smarter not harder: Coupling implementation to de-implementation.Lower mean blood glucose during short-term intensive insulin therapy is associated with long-term glycemic remission in patients with newly diagnosed type 2 diabetes: Evidence-based recommendations for standardization.Glycemic control in type 2 diabetes: from medication nonadherence to residual vascular risk.Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia.A review of the new GLP-1 receptor agonist/basal insulin fixed-ratio combination products.Glycaemic control in type 2 diabetes patients and its predictors: a retrospective database study at a tertiary care diabetes centre in Ningbo, China.Defining and measuring population health quality of outpatient diabetes care in Israel: lessons from the quality indicators in community health program.Clinical Benefits Over Time Associated with Use of V-Go Wearable Insulin Delivery Device in Adult Patients with Diabetes: A Retrospective Analysis.Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute OutcomesSafety and Efficacy of DPP4 Inhibitor and Basal Insulin in Type 2 Diabetes: An Updated Review and Challenging Clinical Scenarios
P2860
Q30234356-3ACBCD6F-476A-4950-A4F7-4562B81AC140Q31142015-6E9381D8-E1AD-4C0E-8916-616B6D6E94A7Q33786220-445E9777-8854-435E-8630-56AA818DCF5FQ38711105-681D08B1-AEEB-4C16-8336-DCBEFF25D9BCQ38907817-89D9BBEE-3AF5-457B-96E0-D460AE9708DCQ39183556-A2ECBAF0-B6FB-4CD2-99F9-DE860F531FA2Q39296548-DDD9CF98-0A26-4E58-AC7F-F617A9ED9F1BQ40141299-FFEAE4C3-29D2-4918-ACA6-DF7104B942D5Q40281876-6A59E821-B3AE-4515-8742-1F333F47CA01Q42677352-92EB40AD-9737-490D-9C56-F5FD4C2979F8Q47150840-F34D61B0-D800-49D2-98A1-6C4E136019ABQ47246352-815431EA-0B68-43B4-ACA5-87D02D7CA582Q47437450-74389CF9-9835-4318-AD7A-B206A532EBC6Q47615333-C6442C80-6218-43F3-95C2-51AD93A93C52Q47668522-A377DA41-B380-4290-B47B-DC197F647CD1Q48199510-99FD94D3-DB69-4EBB-A324-27113E5968B2Q48265337-092FEC2A-070B-482D-8201-DED88FCFD9CBQ50043733-32CA45C6-8474-401C-A0E5-47291A8BA8C6Q50333496-9E5597B1-A3BD-4B3B-905B-30CFF22047B5Q51244385-9527A933-9B3E-4879-AA9C-98955912EAF0Q54964823-4D48490A-FF83-4E6F-9EB3-8C1CF0F90404Q55279421-DA56C669-ABC8-4AC2-AF61-5B79AA573925Q57477167-F5AC0D5B-755A-4094-8250-57D0ADD7BADAQ58772421-243D6027-260A-46CC-B59E-907D1F997FB1
P2860
Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Trends in Drug Utilization, Gl ...... evere Hypoglycemia, 2006-2013.
@en
Trends in Drug Utilization, Gl ...... evere Hypoglycemia, 2006-2013.
@nl
type
label
Trends in Drug Utilization, Gl ...... evere Hypoglycemia, 2006-2013.
@en
Trends in Drug Utilization, Gl ...... evere Hypoglycemia, 2006-2013.
@nl
prefLabel
Trends in Drug Utilization, Gl ...... evere Hypoglycemia, 2006-2013.
@en
Trends in Drug Utilization, Gl ...... evere Hypoglycemia, 2006-2013.
@nl
P2093
P2860
P50
P356
P1433
P1476
Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013
@en
P2093
Jeph Herrin
Kasia J Lipska
Michael A Steinman
Nilay D Shah
Rozalina G McCoy
Silvio E Inzucchi
Xiaoxi Yao
P2860
P304
P356
10.2337/DC16-0985
P407
P577
2016-09-22T00:00:00Z